(2e)-3-(2-Bromopyridin-4-yl)prop-2-enoic acid, 95+%, 250mg

Z-EDA.HCl, 99.0%, 5g

[NH2Me2][(RuCl((S)-segphos(regR)))2(mu-Cl)3]200mg

Dichlorodecylmethylsilane>95.0%(GC)5mL

L(+)-Nipecotic acid, 97.0%, 5g

Tricyclodecanedimethanol Dimethacrylate (mixture of isomers) (stabilized with MEHQ)>90.0%(GC)500g

5-Aminopyrazine-2-carbaldehyde, 96%, 1g

Pyridin-4-amine perchlorate, 250mg

2-CYANOPIPERIDINE HEMIOXALATE, 95.0%, 1g

2-Bromo-3-fluorobenzotrifluoride, 98.0%, 25g

N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine, 95.0%, 500g

3-Chloro-4-cyanopyridine, 97.0%, 5g

((2S,3S,4S,5S)-3-(benzoyloxy)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-4-methyltetrahydrofuran-2-yl)methyl benzoate, 98%, 5mg